Praxis Precision Medicines Stock Forecast
NASDAQ: PRAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
PRAX analyst consensus
Consensus (19 analysts)
strong_buy
Avg. price target
$644.42+144.52%
- Strong buy 3
- Buy 14
- Hold 1
- Sell 1
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 19 Wall Street analysts covering Praxis Precision Medicines (2026-10-08), 17 rate the stock a buy or strong buy, 1 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $644.42, with a high estimate of $1,201.00 and a low estimate of $188.00. The average target implies upside of 144.5% from the current price of $263.55.
The spread between the highest and lowest targets is 538.8%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for PRAX.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 3 | 16% |
| Buy | 14 | 74% |
| Hold | 1 | 5% |
| Sell | 1 | 5% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $188.00 | -28.67% |
| Average target | $644.42 | +144.52% |
| High target | $1,201.00 | +355.70% |